Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (68)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (2)
Immunology (32)
Inflammation and immunity (53)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info@vib.be
Recent press releases
Investigators at VIB and UGent have developed a tool for more accurate interpretation of biomedical research
23 July 2015
The research group of Prof Peter Vandenabeele (VIB/UGent) recently used tangible examples to demonstrate how the side effects of genetic modification of mice can complicate the interpretation of biomedical research.
Peter Carmeliet is bestowed the title of baron
22 July 2015
With the appointment of seven barons, three baronesses, three knights and an earl, King Philip has raised fourteen people into peerage.
Potential target pathway may pave the way for new therapeutic approaches for fragile X syndrome and autism
16 July 2015
The discovery that it might also contribute to FXS, a neurodevelopmental disorder occurring at a young age, is remarkable.
Researchers at VIB, ULB, KU Leuven uncover new genetic alterations in development of skin cell carcinoma
13 July 2015
“These results will be the foundation of many future studies on the genetic aberrations controlling cancer development” - Diether Lambrechts, VIB-KU Leuven
Genome Engineering and Synthetic Biology - Tools and Technologies - 2nd edition
13 July 2015
Genome Engineering and Synthetic Biology are revolutionizing Life Sciences. We are pleased to announce the 2nd edition of GESB in January, 2016.
Applied Bioinformatics in Life Sciences
13 July 2015
We are delighted to invite you to the VIB Conference “Applied Bioinformatics in life sciences” in the historical center of Leuven (Belgium) on March 17-18, 2016.
New insights in function of fatty acids in metabolism of endothelial cells
10 July 2015
Sandra Schoors, Ulrike Bruning, Sarah-Maria Fendt and Peter Carmeliet (VIB Vesalius Research Center, KU Leuven) have discovered, contrary to all expectations, that fatty acid breakdown is essential for the proliferation of endothelial cells.
Focus on our oceans’ microbiome
6 July 2015
An international team of scientists, including Jeroen Raes, Gipsi Mendez, Karoline Faust and Samuel Chaffron (VIB/KU Leuven), has vastly increased our understanding of microscopic life in the oceans.
549,490 Euros from Stichting Alzheimer Onderzoek (Alzheimer’s Research Foundation) for 6 VIB researchers
3 July 2015
In 2014, Stichting Alzheimer Onderzoek (SAO) awarded a total of 991,390 Euros in funding (2015 - 2016) to 12 research projects.
Anxiety increases the risk of gastrointestinal infection and long-term complications
2 July 2015
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system.
VIB conference - Metabolism in Cancer and Stromal Cells
1 July 2015
From September 8 – 10, 2015 VIB will host the interdisciplinary meeting on “Metabolism in Cancer and Stromal Cells” in Leuven.
How to kill a spill
1 July 2015
Tips and tricks on how can clean spills in teh lab safely.
Peter Vandenabeele (VIB-UGent) receives FWO excellence prize
1 July 2015
Every five years, FWO Flanders selects five exceptional scientists in Flanders who play an international leading role in their field and have pushed the boundaries of their field.
Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine
30 June 2015
Immunovaccine Inc. announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine.
Oncurious NV Appoints Prof Dr Peter Carmeliet as its Chief Scientific Strategy Advisor
26 June 2015
Oncurious NV, an oncology company focused on the development of innovative medicines for the treatment of pediatric tumors, today announces the appointment of Prof. Dr Peter Carmeliet as its Chief Scientific Strategy Advisor.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
Next»
Page Content Zone 2
Page Content Zone 3